Proteasome Inhibitors [MoA] - N0000175075

Pharmacologic Class Information

Pharmacologic Code N0000175075
Pharmacologic Name Proteasome Inhibitors
Pharmacologic Uses
  • proteasome inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Proteasome Inhibitors

The following table contains 38 products whose active ingredient are classified under the same pharmacologic class Proteasome Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0143-9098Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0409-1700Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0409-1703Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0409-1704Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0781-3258Bortezomib Non-Proprietary Name: Bortezomib For InjectionInjection, Powder, Lyophilized, For SolutionIntravenousSandoz IncACTIVE
10019-991Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBaxter Healthcare CorporationACTIVE
25021-244Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
43598-426Bortezomib Non-Proprietary Name: BortexomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousDr.reddy's Laboratories, Inc.ACTIVE
43598-865Bortezomib Non-Proprietary Name: BortexomibInjection, Powder, Lyophilized, For SolutionIntravenousDr.reddy's Laboratories IncACTIVE
50742-484Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousIngenus Pharmaceuticals, LlcACTIVE
51817-586Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousPharmascience Inc.ACTIVE
55150-337Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousAuromedics Pharma LlcACTIVE
60505-6050Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousApotex CorpACTIVE
63020-049Velcade Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
63020-078Ninlaro Non-Proprietary Name: IxazomibCapsuleOralMillennium Pharmaceuticals, Inc.ACTIVE
63020-079Ninlaro Non-Proprietary Name: IxazomibCapsuleOralMillennium Pharmaceuticals, Inc.ACTIVE
63020-080Ninlaro Non-Proprietary Name: IxazomibCapsuleOralMillennium Pharmaceuticals, Inc.ACTIVE
63020-230Ninlaro Non-Proprietary Name: IxazomibCapsuleOralTakeda Pharmaceuticals America, Inc.ACTIVE
63020-390Ninlaro Non-Proprietary Name: IxazomibCapsuleOralTakeda Pharmaceuticals America, Inc.ACTIVE
63020-400Ninlaro Non-Proprietary Name: IxazomibCapsuleOralTakeda Pharmaceuticals America, Inc.ACTIVE
63323-721Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenousFresenius Kabi Usa, LlcACTIVE
63323-821Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
67184-0530Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousQilu Pharmaceutical Co., Ltd.ACTIVE
68001-534Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
68001-540Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
68001-541Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
70511-161Bortezomib Non-Proprietary Name: BortezomibInjectionIntravenousMaia Pharmaceuticals, Inc.ACTIVE
70511-162Bortezomib Non-Proprietary Name: BortezomibInjectionIntravenousMaia Pharmaceuticals, Inc.ACTIVE
70710-1411Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousZydus Pharmaceuticals Usa Inc.ACTIVE
70771-1708Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousZydus Lifesciences LimitedACTIVE
70860-225Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousAthenex Pharmaceutical Division, Llc.ACTIVE
71288-118Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
72205-183Bortezomib Non-Proprietary Name: BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousNovadoz Pharmaceuticals LlcACTIVE
72266-243Bortezomib Non-Proprietary Name: BortezomibInjectionIntravenousFosun Pharma Usa IncACTIVE
72266-244Bortezomib Non-Proprietary Name: BortezomibInjectionIntravenousFosun Pharma Usa IncACTIVE
76075-101Kyprolis Non-Proprietary Name: CarfilzomibInjection, Powder, Lyophilized, For SolutionIntravenousOnyx Pharmaceuticals, Inc.ACTIVE
76075-102Kyprolis Non-Proprietary Name: CarfilzomibInjection, Powder, Lyophilized, For SolutionIntravenousOnyx Pharmaceuticals, Inc.ACTIVE
76075-103Kyprolis Non-Proprietary Name: CarfilzomibInjection, Powder, Lyophilized, For SolutionIntravenousOnyx Pharmaceuticals, Inc.ACTIVE